Skip to main content
Premium Trial:

Request an Annual Quote

Andrew Jackson

AltheaDx has appointed Andrew Jackson as CFO. Jackson joins AltheaDx from Celladon, where he served as CFO and principal accounting officer. Prior to Celladon, he held senior finance positions at various life science and technology companies where he had experience with mergers and acquisitions, treasury management, capital and debt financing, and financial planning.

The Scan

Push Toward Approval

The Wall Street Journal reports the US Food and Drug Administration is under pressure to grant full approval to SARS-CoV-2 vaccines.

Deer Exposure

About 40 percent of deer in a handful of US states carry antibodies to SARS-CoV-2, according to Nature News.

Millions But Not Enough

NPR reports the US is set to send 110 million SARS-CoV-2 vaccine doses abroad, but that billions are needed.

PNAS Papers on CRISPR-Edited Cancer Models, Multiple Sclerosis Neuroinflammation, Parasitic Wasps

In PNAS this week: gene-editing approach for developing cancer models, role of extracellular proteins in multiple sclerosis, and more.